(Q40444196)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Xianjun Yu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

10

Liang Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

6

Kaizhou Jin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

He Cheng

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Chen Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Jiahao Jiang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Yu Lu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Meng Guo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Zhenzhen Zhang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Jin Xu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Quanxing Ni

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

language of work or name

English

0 references

publication date

9 March 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

2 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

2344-2350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

cites work

Cancer statistics, 2016

1 reference

Adjuvant therapy for pancreatic cancer: a review

21 January 2018

1 reference

Combinational therapy: new hope for pancreatic cancer?

21 January 2018

1 reference

CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions

21 January 2018

1 reference

Opportunities and Challenges for Pancreatic Circulating Tumor Cells

21 January 2018

1 reference

Whole genomes redefine the mutational landscape of pancreatic cancer

21 January 2018

1 reference

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies

21 January 2018

1 reference

Liquid biopsies: genotyping circulating tumor DNA

21 January 2018

1 reference

Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

21 January 2018

1 reference

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.

21 January 2018

1 reference

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.

21 January 2018

1 reference

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

21 January 2018

1 reference

Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing

21 January 2018

1 reference

ATM mutations in patients with hereditary pancreatic cancer

21 January 2018

1 reference

Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer

21 January 2018

1 reference

Molecular landscape of pancreatic cancer: implications for current clinical trials

21 January 2018

1 reference

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature

21 January 2018

1 reference

The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Antiangiogenic therapy in oncology: current status and future directions

21 January 2018

1 reference

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study

21 January 2018

1 reference

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

21 January 2018

1 reference

HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies

21 January 2018

1 reference

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

21 January 2018

1 reference

Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer

21 January 2018

1 reference

Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer

21 January 2018

1 reference

Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer

21 January 2018

1 reference

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

21 January 2018

1 reference

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

21 January 2018

1 reference

Detection of circulating tumor DNA in early- and late-stage human malignancies

21 January 2018

1 reference

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.30650

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28205231%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference